Sanofi, Salipro ink research, licensing contract for drug discovery

Nov. 08, 2022 6:38 AM ETSanofi (SNY)By: Ravikash, SA News Editor

Sanofi Distribution Centre in Kirkland, Quebec, Canada.

JHVEPhoto

  • Swedish biotech Salipro Biotech said it entered a research collaboration and license agreement with Sanofi (NASDAQ:SNY) for the discovery of therapeutic biologics against a selected membrane protein drug target.
  • The collaboration will use Salipro expertise in developing stable

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.